This method quantifies the extent to which an intervention lowers the risk of an adverse outcome compared to a control. It represents the proportional decrease in risk achieved by the treatment, intervention, or exposure, relative to the baseline risk observed in the untreated group. For instance, if a disease occurs in 10% of an untreated group but only 5% of a treated group, this metric indicates a 50% diminution in risk.
Understanding this measure is essential for evidence-based decision-making in healthcare and public health. It aids clinicians in assessing the effectiveness of treatments and helps patients understand the potential benefits. Historically, the development of this analytical approach has been pivotal in interpreting clinical trial results and formulating appropriate treatment strategies. It provides a standardized way to compare the efficacy of different interventions across various populations and disease states.